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S U M M A R Y
Mediterranean spotted fever (MSF) is a tick-borne zoonosis caused by Rickettsia conorii. In Italy, about
400 cases are reported every year and nearly half of them occur in Sicily, which is one of the most
endemic regions. Although MSF is mostly a self-limited disease characterized by fever, skin rash, and a
dark eschar at the site of the tick bite called a ‘tache noire’, serious complications are described, mainly in
adult patients. Nevertheless, severe forms of the disease with major morbidity and a higher mortality
risk have been described. We report a fatal case of MSF complicated by rhabdomyolysis, acute renal
failure, and encephalitis in an elderly woman.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-
nc-sa/3.0/).
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Mediterranean spotted fever (MSF) is a tick-borne zoonosis.
The etiological agent is Rickettsia conorii, an obligate intracellular
Gram-negative, rod-shaped bacterium. In Italy, about 400 cases
are reported every year and nearly half of them occur in Sicily,
which is one of the most endemic regions.1
Although MSF is mostly a self-limited disease characterized by
fever, skin rash, and a dark eschar at the site of the tick bite called a
‘tache noire’, serious complications are described, mainly in adult
patients.1,2 Diagnosis is based on epidemiological, clinical, and
laboratory criteria. Concerning therapy, doxycycline is considered
the safest and most efﬁcacious treatment; clarithromycin is
considered a valid alternative, especially in patients with
hypersensitivity to tetracyclines, in pregnant women, and in
children.3,4
We report a fatal case of MSF complicated by rhabdomyolysis,
acute renal failure, and encephalitis.* Corresponding author. Tel.: +39 091 655 4054; fax: +39 091 655 4059.
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license (http://creativecommons.org/licenses/by-nc-sa/3.0/).2. Case report
A 78-year-old woman was admitted to the Infectious Diseases
Unit of the University Hospital of Palermo, Italy, in August 2013,
because of clinical symptoms of continuous–remittent fever (max
38.5 8C), generalized rash, acute renal failure, and progressive loss
of consciousness over 48 h. Her medical history was signiﬁcant for
type II diabetes mellitus and arterial hypertension. The patient
also had a history of acute myocardial infarction and ischemic
stroke.
On admission the patient was in a serious clinical condition
with neurological impairment. Her Glasgow Coma Scale (GCS)
score was 3. Her body temperature was 38 8C, blood pressure was
90/50 mmHg, and she presented an arrhythmic pulse at a high
frequency (heart rate 128 beats/min) and an oxygen saturation of
97%.
On physical examination, she presented a general maculopap-
ular rash with rare petechial elements that involved the palms of
the hands and the soles of the feet. Furthermore we noticed two
dark crusted lesions with a diameter of 50 mm like a ‘tache noire’
on the left thigh. On chest auscultation the patient had normal
vesicular breathing sounds. Cardiac auscultation detected an
arrhythmic pulse and there was evidence of atrial ﬁbrillation
on electrocardiogram. Abdominal examination revealed just
hepatomegaly.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-SA
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cell (WBC) count 12.04  109/l with 87.4% polymorphonuclear
neutrophils), acute renal failure (uremia 216 mg/dl, creatinine
3.13 mg/dl, hyperkalemia, and hypoalbuminemia), increased
creatine kinase (>1400 U/l) and myoglobin (>2000 mg/dl),
elevated transaminase blood levels (aspartate aminotransferase
176 U/l, alanine aminotransferase 79 U/l), increased lactate
dehydrogenase (LDH; 1041 U/l) and D-dimer (8238 ng/ml), an
international normalized ratio (INR) of 0.9, activated partial
thromboplastin time (APTT) of 33 s, and C-reactive protein
>27 mg/dl.
Brain computed tomography (CT) scans taken at admission and
after 48 h were normal. A chest and abdomen CT scan was normal.
As meningoencephalitis was suspected, a lumbar puncture was
done on the ﬁrst day of admission and revealed clear cerebrospinal
ﬂuid (CSF) with a normal liquor tension, containing 5  106WBC/l,
an elevated sugar content of 96 mg/dl, and negative Pandy
reaction.
Routine microbiological cultures and PCR for herpes simplex
virus from the CSF were negative, as were two blood culture sets.
Rickettsia PCRs on blood and CSF were negative. Serological tests to
detect R. conorii IgM and IgG (indirect immunoﬂuorescence assay
(IFI) and ELISA) gave negative results. The R. conorii IFI and ELISA
were repeated after 1 week, showing elevated IgM and IgG titers
(IFI IgM–IgG 1/320–1/640; ELISA IgM–IgG 1/200–1/800).
Empiric antibiotic therapy was started with intravenous (IV)
chloramphenicol and IV levoﬂoxacin. After 3 days of hospitaliza-
tion the fever disappeared and the maculopapular rash improved.
Therapy with corticosteroids and mannitol was started with an
initial slight improvement revealed by neurological examination.
Because of the progressive acute renal failure, hemodialysis
sessions were initiated in agreement with the nephrologist. On
the ﬁfth day of hospitalization her clinical condition worsened and
the patient died after 10 days of hospitalization due to cardiac
arrest during a hemodialysis session.
3. Discussion
Most cases of MSF follow a benign course. However, severe
forms of the disease with major morbidity and a higher mortality
risk have been described.1,2,5 Few cases of spotted fever
rickettsiosis have been reported in HIV-positive patients.6
The pathogenesis of MSF complications results from vascular
injury, which may be responsible for organ dysfunction of different
organs. Renal impairment has been described frequently as a
consequence of severe MSF. Several mechanisms of renal damage
during MSF have been reported and the prognosis is determined by
the type of renal disease and by early treatment.7
Rhabdomyolysis is a syndrome characterized by elevated
serum concentrations of creatine phosphokinase (CPK) and
myoglobin, as well as myoglobinuria, which can lead to renal
dysfunction. There are several causes of rhabdomyolysis: the use of
statins, trauma, prolonged immobilization, infection, electrolyte
and endocrine abnormalities, and genetic or connective tissue
disorders. A viral etiology is the most frequent among the possible
infectious causes.8 Benign acute myositis secondary to R. conorii
infection has been described in the literature, as well as
histologically documented pictures of myositis, but no case ofrhabdomyolysis in the course of MSF has been described.
Rhabdomyolysis due to R. conorii infection linked with acute renal
failure has not been reported previously.
In our case report, the patient was not taking any drug or going
through any situation that could explain the appearance of
rhabdomyolysis.9 The exact pathogenesis of Rickettsia-induced
myopathy remains unclear, but we are led to believe that R. conorii,
like the inﬂuenza virus, may act by direct invasion and immune-
mediated mechanisms.8
Neurological complications of MSF include clinical pictures of
meningitis and meningoencephalitis.10,11 The pathogenetic
mechanism responsible for the brain damage is thought to be
the invasion and multiplication in vascular endothelial cells,
resulting in widespread vasculitis of capillaries, arterioles, and
small arteries. Our patient had a clinical presentation of
meningoencephalitis, but the chemical–physical characteristics
of the CSF, as well as the search for Rickettsia by PCR, were
negative.
An early diagnosis and prompt initiation of antibiotic therapy
are crucial to the outcome of the disease. Doxycycline is the gold
standard treatment for MSF in adults. In severe and complicated
cases, the use of high doses of doxycycline (200 mg twice daily) is
reported to give good results, as well as the use of chloramphenicol
in cases of neurological involvement.
Our case demonstrates the importance of recognizing rhabdo-
myolysis as a complication of R. conorii infection and its potential
association with life-threatening acute renal failure and electrolyte
imbalances. Furthermore we recommend close monitoring of
CPK and symptoms of myopathy in all patients with MSF.
Conﬂict of interest: The authors declare that they have no
competing interests or funding.
References
1. Colomba C, Saporito L, Polara VF, Rubino R, Titone L. Mediterranean spotted
fever: clinical and laboratory characteristics of 415 Sicilian children. BMC Infect
Dis 2006;6:60.
2. Saporito L, Giammanco GM, Rubino R, Ingrassia D, Spicola D, Titone L, et al.
Severe Mediterranean spotted fever complicated by acute renal failure and
herpetic oesophagitis. J Med Microbiol 2010;59(Pt 8):990–2.
3. Cascio A, Colomba C, Antinori S, Paterson DL, Titone L. Clarithromycin
versus azithromycin in the treatment of Mediterranean spotted fever in
children: a randomized controlled trial. Clin Infect Dis 2002;34:154–8.
4. Cascio A, Colomba C, Di Rosa D, Salsa L, di Martino L, Titone L. Efﬁcacy and
safety of clarithromycin as treatment for Mediterranean spotted fever in
children: a randomized controlled trial. Clin Infect Dis 2001;33:409–11.
5. Colomba C, Saporito L, Colletti P, Mazzola G, Rubino R, Pampinella D, et al. Atrial
ﬁbrillation in Mediterranean spotted fever. J Med Microbiol 2008;57(Pt
11):1424–6.
6. Colomba C, Siracusa L, Madonia S, Saporito L, Bonura C, De Grazia S, et al. A case
of spotted fever rickettsiosis in a human immunodeﬁciency virus-positive
patient. J Med Microbiol 2013;62(Pt 9):1363–4.
7. Montasser DI, Zajjari Y, Alayoud A, Bahadi A, Aatif T, Hassani K, et al. Acute renal
failure as a complication of Mediterranean spotted fever. Nephrol Ther
2011;7:245–7.
8. Ayala E, Kagawa FT, Wehner JH, Tam J, Upadhyay D. Rhabdomyolysis associated
with 2009 inﬂuenza A (H1N1). JAMA 2009;302:1863–4.
9. Colomba C, Rubino R, Siracusa L, Mazzola G, Titone L. Rhabdomyolysis associ-
ated with the co-administration of daptomycin and pegylated interferon a-2b
and ribavirin in a patient with hepatitis C. J Antimicrob Chemother 2012;67:249–
50.
10. Kularatne SA, Weerakoon KG, Rajapakse RP, Madagedara SC, Nanayakkara D,
Premaratna R. A case series of spotted fever rickettsiosis with neurological
manifestations in Sri Lanka. Int J Infect Dis 2012;16:e514–7.
11. Duque V, Ventura C, Seixas D, Barai A, Mendonc¸a N, Martins J, et al. Mediterra-
nean spotted fever and encephalitis: a case report and review of the literature.
J Infect Chemother 2012;18:105–8.
